Vitritya Labs Private Limited

In their own words

1. The Ongoing Struggle with Invasive Blood Testing in Cancer Care :Cancer patients undergoing various treatment modalities, such as chemotherapy, radiotherapy, immunotherapy, and surgery, face a significant and recurrent challenge in the form of invasive and burdensome blood tests. 2. Routine Hemogram Testing: The current standard involves repeated testing of complete hemogram parameters, including white blood cells, red blood cells, and platelets, to monitor treatment efficacy and detect potential complications. 3. Balancing Hardships and Timely Intervention Risks: This process not only imposes logistical, financial, and emotional hardships on patients but also introduces the risk of delayed intervention due to the time lag between tests. 4. Urgent Call for Innovation- Real-Time Blood Cell Monitoring in Cancer Care : The need for a novel, non-invasive device to monitor blood cell lines in real-time is critical, as it addresses the pressing issues of patient well-being, treatment optimization, and timely complication management. 5. Revolutionizing Cancer Care: Non-Invasive Blood Monitoring Solution : Our proposed solution seeks to revolutionize cancer care by introducing a non-invasive blood monitoring device, alleviating the burdens associated with traditional testing methods and empowering healthcare professionals with timely, actionable insights for enhanced patient care.•Non-Invasive device which can monitor the cell line count, cell lineages giving qualitative analysis (Red, white and platelet counts). This benefits the doctors, patients and hospitals to have access to the real-time data from the patient. This helps the number of visits to the hospitals, cost reduction for patient and reduce the burden on the hospitals. Ex, In-case of Febrileneutropina cases early detection of this can save the lives as we will be able to detect this using the non-invasive wearable device.•We will improvise this device with the help of incubation and also complete the clinical trials which provides us with all strengths to place the device in the market. •Novelty of this device is that there is a hardware (non-invasive) and with the combination of the algorithm we qualify for the patency.

Written by the company on its public Startup India profile. Not verified by us.

Is this your company?

Everything here comes from public government records. If something is wrong, the authoritative place to correct it is the Startup India portal itself, and we will pick the correction up on the next monthly snapshot. To flag an error on our side, use the report link or write to trust@indianstartupmap.com.

How we built this page Where the data comes from How you may reuse it